GL1X · GenesisL1 explorer

MolNFT v1 · #156796 · protein + RNA

Human ARGONAUTE2-mir-27A bound to HSUR1 target RNA

6MFN · Protein argonaute-2: “Human ARGONAUTE2-mir-27A bound to HSUR1 target RNA”. X-ray diffraction, 1 ligand (IPH), 8 pockets (best druggability 0.78). MolNFT v1 #156796 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6MFN
Type
protein + RNA
Length
820 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein argonaute-2; RNA (5'-R(P*UP*UP*CP*AP*CP*AP*GP*UP*G)-3'); RNA…
EC
3.1.26.-
UniProt
Q9UKV8
Ligands
IPH
Pockets
8 · best druggability 0.78

Structure

x-ray diffraction · 3 distinct chains · 32% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtein argonaute-2 (EC 3.1.26.-)protein80332% helix, 27% strandQ9UKV8
CRNA (5'-R(P*UP*UP*CP*AP*CP*AP*GP*UP*G)-3')rna8——
ERNA (5'-R(P*UP*CP*UP*GP*UP*GP*AP*UP*AP*A)-3')rna9——

Ligands and binding sites

  • IPH · Phenol · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110680.780.8063empty
25130.660.7852empty
31730.580.8218empty
42630.570.7833empty
52050.560.7926empty

Interfaces

3 interfaces between chains.

  • A–C · 1110 Ų buried · 36 hydrogen bonds · protein-nucleic
  • A–E · 438 Ų buried · 6 hydrogen bonds · protein-nucleic
  • C–E · 325 Ų buried · 26 hydrogen bonds · nucleic-nucleic

Compared structures

  • 6MFN · Human Argonaute2-miR-27a bound to HSUR1 target RNA · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9UKV8 · AlphaFold monomer V2.0 prediction for protein argonaute-2 (Q9UKV8) · a predicted model of the same protein · chain A against A, TM-score 0.91

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.